Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 20, 2013

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Quillivant XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Xeljanz	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Aubagio	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Eliquis	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Sklice	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Gattex	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Oxtellar XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tudzorza Pressair	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Natroba	New Drug Appeal	Require Prior Approval	Prior Approval Required
Brilinta	PDL Appeal	Require Prior Approval	Prior Approval Required
Latuda	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed